SCHEMBL23675003

SCHEMBL23675003

CCOC(=O)c1cn(C)c(=O)cc1CC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.70
BAZ2A Q9UIF9 1/20 0.70
MAP2K2 P36507 1/20 0.51
MAP2K1 Q02750 1/20 0.51
TSHR P16473 1/20 0.49
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 7/20 0.44
GAA P10253 6/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 3/20 0.43
MAPK1 P28482 1/20 0.42
GLA P06280 2/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14528963 0.89 BAZ2B (0.65) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL12344058 0.85 BAZ2B (0.72) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL388580 0.84 BAZ2B (0.70) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL392754 0.83 BAZ2B (1.00) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL23147153 0.81 BAZ2B (0.67) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL23675007 0.80 BAZ2B (0.47) BAZ2BBAZ2AMAP2K2MAP2K1ALDH1A1
SCHEMBL26088154 0.79 BAZ2B (0.63) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL6529175 0.78 BAZ2B (0.89) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL28343461 0.74 BAZ2B (0.57) BAZ2BBAZ2AMAP2K2MAP2K1TSHR
SCHEMBL12344059 0.73 BAZ2B (0.56) BAZ2BBAZ2AMAP2K2MAP2K1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed
WO-2021151062-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERISTY (US) 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 BAZ2B 1412/4885BAZ2A 1180/4885MAP2K2 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.